The absolute oral bioavailability (BA) of 150-mg and bioequivalence (BE) of six 25- and one 150-mg erlotinib (E) tablets, a small molecule inhibitor of the epidermal growth factor receptor (EGFR), in healthy volunteers
2005 ◽
Vol 23
(16_suppl)
◽
pp. 3163-3163
2005 ◽
Vol 34
(3)
◽
pp. 420-426
◽
2009 ◽
Vol 31
◽
pp. 2332-2348
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 2032-2032
◽
2006 ◽
Vol 46
(3)
◽
pp. 282-290
◽
2003 ◽
Vol 57
(2)
◽
pp. S293-S294
◽
2019 ◽
Vol 510
(1)
◽
pp. 42-47